|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
KZIA
|
Kazia Therapeutics Limited
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MBIO
|
Mustang Bio, Inc.
|
US
|
NASDAQ
|
|
NCNA
|
NuCana plc
|
US
|
NASDAQ
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
RFL
|
Rafael Holdings, Inc.
|
US
|
NYSE
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|